Copyright
©2013 Baishideng Publishing Group Co.
World J Obstet Gynecol. Nov 10, 2013; 2(4): 80-86
Published online Nov 10, 2013. doi: 10.5317/wjog.v2.i4.80
Published online Nov 10, 2013. doi: 10.5317/wjog.v2.i4.80
Ref. | Year | No. of women | Initial dosage (μg) | Dosing interval | Efficacy | Adverse effects | Cesarean rate (%) |
Hofmeyr et al[18] | 2001 | 25 | 20 | q2h | 72% VD within 32 h | 8% UH | 20.0 |
Hofmeyr et al[19] | 2001 | 346 | 20 | q2h | 62% VD within 24 h | 4% UH | 16.0 |
Matonhodze et al[24] | 2003 | 176 | 20 | q2h | 60.2% VD within 24 h | 4% UH, 8% UT | 14.0 |
Cheng et al[20] | 2006 | 77 | 20 | q1h | 93.5% VD within 24 h | 0% UH, 9.1% UT | 3.9 |
Bricker et al[25] | 2008 | 375 | 20 | q2h | 76% VD within 24 h | 2% UH, 5% UT | 14.0 |
Cheng et al[21] | 2008 | 101 | 20 | q1h | 94.1% VD within 24 h | 0% UH, 6.9% UT | 4.0 |
Ho et al[22] | 2010 | 112 | 20 | q1h | 94.6% VD within 24 h | 0% UH, 7.1% UT | 3.6 |
Souza et al[23] | 2010 | 30 | 20 | q1h | 80% VD within 24 h | 13.3% UT | 20.0 |
- Citation: Cheng SY. Individualized misoprostol dosing for labor induction or augmentation: A review. World J Obstet Gynecol 2013; 2(4): 80-86
- URL: https://www.wjgnet.com/2218-6220/full/v2/i4/80.htm
- DOI: https://dx.doi.org/10.5317/wjog.v2.i4.80